These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 4304976
1. Effect of hormones on the growth of virus-transformed hamster prostatic tissue. Fraley EE, Paulson DF. Surg Forum; 1968; 19():544-5. PubMed ID: 4304976 [No Abstract] [Full Text] [Related]
2. SV40-transformed hamster prostatic tissue: a model of human prostatic malignancy. Paulson DF, Fraley EE, Rabson AS, Ketcham AS. Surgery; 1968 Jul; 64(1):241-7. PubMed ID: 4298081 [No Abstract] [Full Text] [Related]
4. Endocrine treatment of cancer of the prostate. Madsen PO, Pedersen JF, Knuth OE. Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084 [No Abstract] [Full Text] [Related]
5. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)]. Straube W, Braun JS. Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442 [No Abstract] [Full Text] [Related]
6. Progynon, a depot preparation with oestrogenic action, in the treatment of prostatic carcinoma. Birke G, Wadström LB. Acta Chir Scand; 1965 Oct; 130(4):388-92. PubMed ID: 5842513 [No Abstract] [Full Text] [Related]
7. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate. Ishibe T, Usui T, Nihira H. J Urol; 1974 Aug; 112(2):237-40. PubMed ID: 4843340 [No Abstract] [Full Text] [Related]
8. Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Prout GR, Brewer WR. Cancer; 1967 Nov; 20(11):1871-8. PubMed ID: 4168724 [No Abstract] [Full Text] [Related]
9. [Effects of gonadal hormones on the lipid spectrum of plasma]. Para Cabello J, Jover Sanz E, Velasco Alonso R. Rev Clin Esp; 1974 Sep 15; 134(5):449-60. PubMed ID: 4438740 [No Abstract] [Full Text] [Related]
10. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen. Noland JL, Amin M. Invest Urol; 1980 May 15; 17(6):506-9. PubMed ID: 7372439 [Abstract] [Full Text] [Related]
11. [Determination of serum acid phosphatase and its isoenzymes]. Ishibe T, Usui T, Tanaka K. Nihon Rinsho; 1976 May 15; 34 suppl():2521-35. PubMed ID: 792523 [No Abstract] [Full Text] [Related]
12. [Contribution on the clinical aspects of prostatic carcinoma]. Sladczyk E. Z Arztl Fortbild (Jena); 1967 Jul 01; 61(13):657-60. PubMed ID: 5598256 [No Abstract] [Full Text] [Related]
13. [Hormone therapy in carcinoma of the prostate]. Marberger H. Wien Klin Wochenschr; 1966 Jul 22; 78(29):512-4 passim. PubMed ID: 5992834 [No Abstract] [Full Text] [Related]
14. The effects of castration, testosterone and oestrogen on epithelial and stromal growth and morphology of the Dunning (R3327H) prostatic adenocarcinoma. Damber JE, Landström M, Bergh A, Tomic R. Scand J Urol Nephrol Suppl; 1988 Jul 22; 110():145-8. PubMed ID: 3187402 [No Abstract] [Full Text] [Related]
15. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer]. Hájek J, Hanselová M, Vrubel F. Vnitr Lek; 1981 Sep 22; 27(9):852-60. PubMed ID: 7293030 [No Abstract] [Full Text] [Related]
16. SV 40 virus transformed prostatic carcinoma in the hamster. II. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer. Abdalla AM, Oliver JA. Invest Urol; 1971 Mar 22; 8(5):488-93. PubMed ID: 4326620 [No Abstract] [Full Text] [Related]
17. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. Huggins C, Hodges CV. J Urol; 2002 Jul 22; 168(1):9-12. PubMed ID: 12050481 [No Abstract] [Full Text] [Related]
18. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate. Mackler MA, Liberti JP, Smith MJ, Koontz WW, Prout GR. Invest Urol; 1972 Mar 22; 9(5):423-5. PubMed ID: 5016026 [No Abstract] [Full Text] [Related]
19. [Initial experience with ethinyl estradiol sulfonate (J 96) in the therapy of prostate carcinoma]. Guddat HM, Schnorr D, Dörner G, Stahl F, Rohde W. Z Urol Nephrol; 1979 Mar 22; 72(3):153-7. PubMed ID: 380227 [Abstract] [Full Text] [Related]